ESC 365 - TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome

ESC Professional Premium Access

TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome

Session: HOT LINE 10

Topic: Pharmacotherapy

Speaker: Professor A. Jeppsson (Gothenburg, SE)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Professor Anders Jeppsson

Sahlgrenska University Hospital, Gothenburg (Sweden)

4 presentations

0 follower

11 more presentations in this session

NEWTON-CABG CardioLink-5: Evolocumab and Saphenous Vein Graft Patency

Speaker: Professor S. Verma (Toronto, CA)

Discussant review - NEWTON-CABG CardioLink-5

Speaker: Professor F. Mach (Geneva, CH)

Panel discussion - NEWTON-CABG CardioLink-5

Discussant review - TACSI

Speaker: Doctor J. Eikelboom (Hamilton, CA)

Panel discussion - TACSI

Access the full session

HOT LINE 10

Speakers: Professor A. Jeppsson, Professor S. Verma, Professor F. Mach, Doctor J. Eikelboom

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

Related content

ESC Premium Access

NEWTON-CABG CardioLink-5: Evolocumab and Saphenous Vein Graft Patency

1 September 2025

ESC Premium Access

The TOP-CABG trial

1 September 2025

ESC Premium Access

OPINION Trial: 1-Year Outcomes

1 September 2025

ESC 365 is supported by

novartis

Explore sponsored resources